Naudingos nuorodos
Information for the applicants/Marketing authorisation holders

The State Medicines Control Agency under the Ministry of Health of the Republic of Lithuania informs that form the 1st of January 2020 names of the medicinal products in MR / DC authorisation procedures will be evaluated during the validation, the whole procedure and in the national phase only. When applying for name change variation - during variation procedures.

For marketing authorisation applications under the national procedure, the possibility for evaluation of the names of medicinal products prior to the submission of applications for registration remains unchanged. More information you can find here.